|
English
|
正體中文
|
简体中文
|
2828323
|
|
???header.visitor??? :
32195615
???header.onlineuser??? :
6308
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"lim dwt"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
中山醫學大學 |
2021 |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang, GC; Lam, DCL; Tsai, CM; Chen, YM; Shih, JY; Aggarwal, S; Wang, SH; Kim, SW; Kim, YC; Wahid, I; Li, RB; Lim, DWT; Sriuranpong, V; Chan, RTT; Lorence, RM; Carriere, P; Raabe, C; Cseh, A; Park, K |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|